[1] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[2] |
SU Xin, FAN Wenyi, XU Xinye, XU Xuedong.
Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 442-447.
|
[3] |
LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan.
Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 481-486.
|
[4] |
LYU Yi, ZHANG Xinyu, NIE Huifang, LI Xun.
Analysis of cancer mortality trend of urban residents in Shenyang,2013—2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 629-634.
|
[5] |
JIANG Zhou, HUANG Haixin, CHEN Dagui, YANG Hui, WU Sibei, XU Zhuohua, LU Ying.
Risk factors of vertebral artery stenosis after intensity-modulated radiation therapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(3): 347-351.
|
[6] |
LIU Jinlu, QIN Xingan, LI Changhua, LUO Yihuan, CHEN Junqiang.
Risk factors and prognostic analysis of lymph node metastasis in No.14v group in gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 69-74.
|
[7] |
WU Yuanyuan, WANG Jun, MAO Aihong, FAN Xiangda, ZHANG Jianwei, DUAN Ying.
Establishment and verification of a scoring system for predicting central lymph node metastasis in papillary thyroid carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 498-502.
|
[8] |
Qin Yijia,Huang Bing,Lao Qifang,Zhang Lizhen.
Effect of different ventilation modes on the expression of S100A8 protein in patients undergoing pulmonary lobectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 465-468.
|
[9] |
Liu Lingfeng,Geng Yichao,OuYang Weiwei,Ma Zhu,Li Qingsong,Li Mei, Wang Yu,Luo Daxian,Yang Wengang,Su Shengfa,He Zhixu,Lu bing.
Comparison of clinical efficacy of cisplatin combined with pemetrexed or docetaxel in stage Ⅳ lung adenocarcinoma based on propensity score matching
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 290-294.
|
[10] |
Hu Hongbo,Lei Hao,Mo Qiyan,Li Ling,Qu Song,Liang Xia,Zhu Xiaodong,Zhao Wei.
Clinical characteriestics of second primary tumors in patients with nasopharyngeal carci-noma after intensity-modulated radiotherapy:series of 527 cases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 305-309.
|
[11] |
Yu Xueting,Yang Bo,Wei Zheng,Huang Gaoming.
Factors influencing image T residue at the end of intensity-modulated radiotherapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 221-225.
|
[12] |
Xu Yi,Tang Shicong, Zhou xin,Xu Xiang,Huang Yaoyuan, Wang Shoufeng,Pan Hong.
Relationship between clinicopathological features of primary human non-small cell lung cancer and their tumorigenicity in nude mice
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 128-132.
|
[13] |
Liang Liudan,Li Yani,Song Xiangqun,Zhou Shaozhang.
Role of the mTOR signaling pathway in the ability of 17-DMAG to overcome acquired resistance to alectinib in the H3122 lung cancer cell line positive for the EML4-ALK fusion gene
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 111-118.
|
[14] |
Zhao Yifan,Xiao Chunyang,Xian Lei.
Expression and clinical significance of angiopoietin-1 mRNA in lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 139-142.
|
[15] |
Chen Qun,Shi Qin,Xie Qiang.
Preliminary study of recombinant human endostatin (Endostar) combined with concurrent intensity-modulated radiation therapy for inoperable local advanced non-small cell lung cancer in elderly patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 142-145.
|